Triple gastrointestinal prophylactic therapy following high-power short-duration posterior left atrial wall ablation

Creative Commons License

Məmmədov M., Candemir B., Esenboğa K., Altin A. T.

INDIAN HEART JOURNAL, vol.72, no.4, pp.306-308, 2020 (ESCI)

  • Nəşrin Növü: Article / Article
  • Cild: 72 Say: 4
  • Nəşr tarixi: 2020
  • Doi nömrəsi: 10.1016/j.ihj.2020.06.007
  • jurnalın adı: INDIAN HEART JOURNAL
  • Jurnalın baxıldığı indekslər: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Səhifə sayı: pp.306-308
  • Adres: Bəli

Qısa məlumat

The purpose of this study is to investigate incidence of gastrointestinal symptoms and complications in patients who underwent high-power short-duration (HPSD), posterior left atrial wall isolation during atrial fibrillation ablation and thereafter have received gastrointestinal prophylactic regimen consisting of sucralfate, proton-pump inhibitor and colchicine. Patients were followed and assessed at baseline, up until 6th month following the procedures.Among 115 patients who were included, 5 patients (4.3%) reported gastrointestinal symptoms at follow-up. No complications were diagnosed during the follow-up. In conclusion, the HPSD along with prophylactic regimen has been associated with low incidence of gastrointestinal adverse events.